These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11301824)

  • 21. [Progress in hepatitis diagnosis].
    Grob PJ; Joller-Jemelka HI
    Praxis (Bern 1994); 1995 May; 84(19):547-54. PubMed ID: 7792463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis vaccination and prophylaxis.
    Nguyen CT; Tran TT
    Clin Liver Dis; 2009 May; 13(2):317-29. PubMed ID: 19442921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy.
    Margolis HS; Shapiro CN
    Vaccine; 1992; 10 Suppl 1():S85-7. PubMed ID: 1335667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
    Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
    Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining hepatitis A and B vaccination in children and adolescents.
    Van Damme P; Van der Wielen M
    Vaccine; 2001 Mar; 19(17-19):2407-12. PubMed ID: 11257370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis A and B screening and vaccination rates among patients with chronic liver disease.
    Ramirez JC; Ackerman K; Strain SC; Ahmed ST; de Los Santos MJ; Sears D
    Hum Vaccin Immunother; 2016; 12(1):64-9. PubMed ID: 26836326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
    Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
    Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: vaccination and viral hepatitis - current status and future prospects.
    Koff RS
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1285-92. PubMed ID: 17868433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.
    Koff RS
    J Clin Gastroenterol; 2001 Jul; 33(1):20-6. PubMed ID: 11418785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral hepatitis: global goals for vaccination.
    Lavanchy D
    J Clin Virol; 2012 Dec; 55(4):296-302. PubMed ID: 22999800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The virology and serology of hepatitis: an overview.
    Teo CG
    Commun Dis Rep CDR Rev; 1992 Sep; 2(10):R109-14. PubMed ID: 1284925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults.
    Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L
    Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.
    MMWR Recomm Rep; 1996 Nov; 45(RR-13):1-16. PubMed ID: 8965784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.